Tianjin Pharmaceutical Da Ren Tang Group
Tianjin Pharmaceutical Da Ren Tang Group Corporation Ltd is a major Chinese pharmaceutical manufacturing enterprise headquartered in Tianjin, China. The company specializes in the research, development, manufacturing, and wholesale distribution of traditional Chinese medicines, patent drugs, western prescription pharmaceuticals, and health nutritional products. Principal revenue is derived through wholesale manufacturing sales of pharmaceutical products to hospitals, medical institutions, and pharmacies across China. Tianjin Pharmaceutical Da Ren Tang Group is publicly listed on the Shanghai Stock Exchange.
2 of the funds FundTelligence covers report a position in Tianjin Pharmaceutical Da Ren Tang Group.
- Legal name
- Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Tianjin Pharmaceutical Da Ren Tang Group
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)